CB Insights examined 25 of the biggest AI trends to determine what’s next for the technology in 2019. The firm assessed each of the trends based on industry adoption and market strength, and categorized them as “necessary,” “experimental,” “threatening” or “transitory.”
Four of the healthcare applications outlined in the report:
1. Medical imaging and diagnostics. CB Insights categorized AI for medical imaging and diagnostics as “necessary,” meaning this application is already experiencing widespread adoption in the industry.
2. Clinical trial enrollment. Clinical trial enrollment fell into the firm’s “experimental” category, as an early-stage trend with a few functional products, despite low adoption so far.
3. Advanced healthcare biometrics. Advanced biometrics — such as using AI to identify disease risk from retinal images or voice patterns — were another AI application in the report’s “experimental” category.
4. Drug discovery. CB Insights determined drug discovery was a “transitory” AI application, meaning that there has been adoption in the industry, but stakeholders are uncertain about the market opportunity.
To download CB Insights’ report, click here.
More articles on artificial intelligence:
Facebook backs AI ethics institute with $7.5M
3M, M*Modal customers relatively favorable toward acquisition deal, survey finds
6 clinical quality, safety issues to consider before deploying AI in the hospital
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.